WARNING: the interactive features of this website use CSS3, which your browser does not support. To use the full features of this website, please update your browser.
Abstract
We have developed a genomic risk score for ischaemic stroke and tested this score in the UK Biobank. Our score was similarly or more predictive compared to several risk factors, such as family history, blood pressure, body mass index, and smoking. We estimate the reductions needed in modifiable risk factors for individuals with different levels of genomic risk and suggest that, for individuals with high genomic risk, achieving risk factor levels recommended by current guidelines may be insufficient to mitigate risk.